Art

J-GLOBAL ID：201702213073156324   Reference number：17A0268641

Acute myeloid leukemia in children: Current status and future directions

小児における急性骨髄性白血病: 現状と将来の方向性

Author (4)： Taga Takashi (Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan) ,  Tomizawa Daisuke (Division of Leukemia and Lymphoma, Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan) ,  Takahashi Hiroyuki (Department of Pediatrics, Toho University, Tokyo, Japan) ,  Adachi Souichi (Human Health Sciences, Kyoto University, Kyoto, Japan)
Material： Pediatrics International (Web)  (Pediatr Int (Web))
Volume： 58  Issue： 2  Page： 71-80  Publication year： 2016 
JST Material Number： U0706A  ISSN： 1442-200X  Document type： Article
Article type： 文献レビュー  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： *Leukemia ,...
Semi thesaurus term： *infantile disease ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0268641&from=J-GLOBAL&jstjournalNo=U0706A") }}

Author keywords (4)： acute myeloid leukemia ,  acute promyelocytic leukemia ,  clinical trial ,  Down syndrome

JST classification (2)： Treatment for tumors in general  (GE03031L) ,  Blood cell tumors(=neoplasms)  (GK04000M)

Substance index (3)： Anthracycline ,  Cytarabine ,  Tretinoin

Reference (85)：

• HoribeK,SaitoAM,Takimoto T et al. Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006-2010): Based on registry data from the Japanese Society of Pediatric Hematology. Int. J. Hematol. 2013; 98: 74-88.
• Tomizawa D, Tabuchi K, Kinoshita A et al. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: Long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children’s Cancer Study Group. Pediatr. Blood Cancer 2007; 49: 127-32.
• Tsukimoto I, Tawa A, Horibe K et al. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia. J. Clin. Oncol. 2009; 27: 4007-13.
• Taga T, Shimomura Y, Hori T et al.Amorphology-based approach for the treatment of children with acute myeloid leukaemia: A report from the Japanese Children’s Cancer and Leukemia Study Group AML 9805 Study. Jpn J. Pediatr. Hematol. 2010; 24: 283-91.
• Tomizawa D, Tawa A, Watanabe T et al. Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children. Leukemia 2013; 27: 2413-6.

Terms in the title (5)： 小児 ,  急性骨髄性白血病 ,  現状 ,  将来 ,  方向性